Skip to content
DrSonia

Type 2 diabetes follow-up + escalation

Visit-ready checklist for glycemic management, medication progression, and patient education continuity.

High-risk workflowLast reviewed September 4, 2026

AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.

Scope

Use for
Primary care follow-up and escalation planning for type 2 diabetes in stable outpatients.
Not for
  • Suspected diabetic ketoacidosis or hyperosmolar crisis.
  • Pregnancy-specific diabetes management.

Immediate actions

  • Review A1c trend, individualized target, glucose patterns, hypoglycemia, adherence, affordability, and adverse effects.
  • Check cardiovascular disease, heart failure, eGFR, and urine ACR because these influence drug choice even when A1c is at target.
  • Review foot problems, retinal-screening status, and ability to use medicines and monitoring safely.

Red flags: escalate now

If any of these are present, stop routine steps and follow the urgency stated. Activate emergency care for instability or findings that need immediate transfer.

  • Suspected ketoacidosis or hyperosmolar crisis, marked dehydration, or altered consciousness requires emergency assessment.
  • Severe hypoglycemia needing assistance requires immediate treatment and urgent review; do not give oral treatment if swallowing is unsafe.
  • Symptomatic hyperglycemia with weight loss or ketosis concern needs prompt assessment for insulin deficiency, rather than waiting for routine follow-up.

First-line plan

  • Support nutrition, activity, and individualized weight goals; use metformin when appropriate and tolerated, with renal-dose checks.
  • In heart failure or CKD, assess eligibility for an SGLT2 inhibitor with proven benefit. In ASCVD or high cardiovascular risk, select an SGLT2 inhibitor or GLP-1 receptor agonist with demonstrated benefit for that indication.
  • Do not make cardiorenal protection conditional only on an elevated A1c; account for contraindications, renal thresholds, cost, and patient preference.
  • Provide medication-specific sick-day and hypoglycemia instructions. Insulin starts require an explicit titration, glucose-monitoring, and early-contact plan.

Follow-up and monitoring

  • Arrange early contact after insulin or hypoglycemia-prone drug changes; do not wait for the next A1c to address safety or titration.
  • Reassess A1c about three months after therapy changes and adjust the plan to the agreed target.
  • Check eGFR and urine ACR at least annually, more often in established CKD; close gaps in foot and retinal screening.

Linked resources

Before the patient leaves

Return precautions you can say as written:

“If symptoms get worse, new warning signs appear, or you cannot follow the plan from this visit, seek urgent care now.”

About this workflow

Clinical owner
Family Medicine Editorial Team
Risk tier
High
Review cadence
Every 6 months
Last reviewed
September 4, 2026AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.
Review status
Evidence current. Next review due March 4, 2027.

References